VEGFA and liver disorder: The dose–volume tolerance of the liver is well established, and multivariate analyses confirm that mean liver dose predicts radiation-induced liver disease (131), helping explain the elevated toxicity under combination therapy, as VEGF pathway inhibition likely impedes recovery from radiation-induced vascular injury.